Everest Medicines Limited (HKG:1952)
Hong Kong
· Delayed Price · Currency is HKD 44.50
-0.70 (-1.55%)
May 16, 2025, 4:08 PM HKT
Everest Medicines Market Cap
Everest Medicines has a market cap or net worth of 14.44 billion as of May 16, 2025. Its market cap has increased by 109.52% in one year.
Market Cap
14.44B
Enterprise Value
13.35B
Revenue
752.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
44.50
Market Cap Chart
Since October 9, 2020, Everest Medicines's market cap has decreased from 20.64B to 14.44B, a decrease of -30.03%. That is a compound annual growth rate of -7.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 14.44B | -7.38% |
| Dec 31, 2024 | 15.59B | 132.87% |
| Dec 29, 2023 | 6.70B | 24.60% |
| Dec 30, 2022 | 5.37B | -47.96% |
| Dec 31, 2021 | 10.33B | -47.98% |
| Dec 31, 2020 | 19.85B | -3.81% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 185.54B |
| Hansoh Pharmaceutical Group Company | 134.38B |
| JD Health International | 124.72B |
| WuXi Biologics | 96.87B |
| Alibaba Health Information Technology | 84.27B |
| Innovent Biologics | 82.39B |
| Akeso | 72.97B |
| Sino Biopharmaceutical | 69.79B |